Avalon GloboCare Files for Best-Efforts Offering as Nasdaq Delisting and Going Concern Warnings Loom
ALBT sits 29% above its 52-week low of $0.21 on light trading volume (0.1× avg).
Summary
Avalon GloboCare filed a preliminary S-1 for a best-efforts offering of stock and warrants, with no minimum amount. The company is fighting Nasdaq delisting and carries a going concern warning, making this a high-stakes capital raise.
Key Events · Financing and Capital Events · ALBT
-
Preliminary S-1 Filed for Best-Efforts Offering
Avalon GloboCare filed an S-1 to offer common stock, pre-funded warrants, and common warrants on a best-efforts basis. No minimum offering amount is required, and the number of shares and price are not yet determined.
-
Nasdaq Delisting Risk
The company received a delisting notice from Nasdaq because its stock trades below $1.00. It has until October 12, 2026 to regain compliance, likely through a reverse stock split.
-
Going Concern Warning
The company's auditor has expressed substantial doubt about its ability to continue as a going concern. With only $0.8M in cash as of March 31, 2026, immediate funding is essential.
-
Recent Distress Financing
In June and July 2026, the company raised $400K through high-cost original issue discount notes and another $400K through Series F convertible preferred stock with mandatory redemption at 125% of stated value.
Analysis · ALBT · Technology
Avalon GloboCare, a micro-cap AI and health tech company trading at $0.27, has filed an S-1 to raise an unspecified amount through a best-efforts offering of common stock and warrants. The filing is preliminary—no price or share count is set—but the context is dire: the company faces Nasdaq delisting (deadline October 12, 2026), has a going concern warning, and recently relied on expensive debt and dilutive preferred stock to stay afloat. This offering is a survival move, but the terms are unknown and the risk of failure is high. If completed, it will heavily dilute existing shareholders; if it fails, the company may run out of cash. The filing also registers resale of shares underlying warrants, adding overhang. Investors should watch for the final prospectus (424B) for pricing, which will determine the dilution impact.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.4% of the 1070 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALBT was trading at $0.27 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.21 to $4.74. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.